SK287154B6 - Vodný intravenózny infúzny roztok alebo farmaceutický roztok obsahujúci levosimendan - Google Patents

Vodný intravenózny infúzny roztok alebo farmaceutický roztok obsahujúci levosimendan Download PDF

Info

Publication number
SK287154B6
SK287154B6 SK327-2002A SK3272002A SK287154B6 SK 287154 B6 SK287154 B6 SK 287154B6 SK 3272002 A SK3272002 A SK 3272002A SK 287154 B6 SK287154 B6 SK 287154B6
Authority
SK
Slovakia
Prior art keywords
solution
levosimendan
pharmaceutically acceptable
amount
aqueous
Prior art date
Application number
SK327-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK3272002A3 (en
Inventor
Reijo B�CKSTR�M
P�Ivi Granvik
Ritva Haikala
Sirpa Pelttari
Eva Saukko
Reija Yrj�L�
Original Assignee
Orion Corporation - Bic 1999212-6
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8555263&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK287154(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corporation - Bic 1999212-6 filed Critical Orion Corporation - Bic 1999212-6
Publication of SK3272002A3 publication Critical patent/SK3272002A3/sk
Publication of SK287154B6 publication Critical patent/SK287154B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SK327-2002A 1999-09-10 2000-09-08 Vodný intravenózny infúzny roztok alebo farmaceutický roztok obsahujúci levosimendan SK287154B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI991925A FI109659B (fi) 1999-09-10 1999-09-10 Levosimendaanin farmaseuttisia liuoksia
PCT/FI2000/000761 WO2001019334A2 (fr) 1999-09-10 2000-09-08 Solutions pharmaceutiques de levosimendan

Publications (2)

Publication Number Publication Date
SK3272002A3 SK3272002A3 (en) 2002-12-03
SK287154B6 true SK287154B6 (sk) 2010-01-07

Family

ID=8555263

Family Applications (1)

Application Number Title Priority Date Filing Date
SK327-2002A SK287154B6 (sk) 1999-09-10 2000-09-08 Vodný intravenózny infúzny roztok alebo farmaceutický roztok obsahujúci levosimendan

Country Status (39)

Country Link
US (2) US6730673B1 (fr)
EP (1) EP1210085B1 (fr)
JP (1) JP4708648B2 (fr)
KR (1) KR100869752B1 (fr)
CN (1) CN1203855C (fr)
AR (1) AR025449A1 (fr)
AT (1) ATE315937T1 (fr)
AU (1) AU771027B2 (fr)
BG (1) BG65827B1 (fr)
BR (1) BRPI0013924B8 (fr)
CA (1) CA2382013C (fr)
CO (1) CO5180582A1 (fr)
CZ (1) CZ303095B6 (fr)
DE (1) DE60025627T2 (fr)
DK (1) DK1210085T3 (fr)
EA (1) EA005067B1 (fr)
EE (1) EE05375B1 (fr)
ES (1) ES2256034T3 (fr)
FI (1) FI109659B (fr)
HK (1) HK1049282B (fr)
HR (1) HRP20020298B1 (fr)
HU (1) HU228340B1 (fr)
IL (2) IL148379A0 (fr)
IS (1) IS2244B (fr)
ME (1) ME00523B (fr)
MX (1) MXPA02002423A (fr)
MY (1) MY125984A (fr)
NO (1) NO331989B1 (fr)
NZ (1) NZ517605A (fr)
PL (1) PL202356B1 (fr)
PT (1) PT1210085E (fr)
RS (1) RS50445B (fr)
SI (1) SI1210085T1 (fr)
SK (1) SK287154B6 (fr)
TR (1) TR200200620T2 (fr)
TW (1) TWI242434B (fr)
UA (1) UA73954C2 (fr)
WO (1) WO2001019334A2 (fr)
ZA (1) ZA200201828B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109659B (fi) * 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
CN100428937C (zh) * 2003-10-30 2008-10-29 北京海合天科技开发有限公司 左西孟旦冷冻干燥组合物
CN100367964C (zh) * 2004-04-29 2008-02-13 王思清 左西孟旦-β环糊精包含物制剂
WO2006087419A2 (fr) * 2005-02-18 2006-08-24 Orion Corporation Methode d'administration de levosimendan
WO2008082871A1 (fr) * 2006-12-28 2008-07-10 Orion Corporation Formulations de levosimendan pour administration parentale
WO2012093404A2 (fr) 2011-01-03 2012-07-12 Gufic Biosciences Limited Formulations parentérales de lévosimendane
US9597425B2 (en) * 2011-10-18 2017-03-21 St. Teresa Medical, Inc. Method of forming a hemostatic product
NZ701609A (en) * 2012-05-18 2016-09-30 Luoda Pharma Pty Ltd Liquid formulation comprising propylene glycol and an inodilator
CN105106113B (zh) * 2015-09-30 2019-07-26 济南康和医药科技有限公司 一种左西孟旦注射液及其制备方法
BR112018009250B1 (pt) * 2015-11-06 2023-12-05 Carinopharm Gmbh Formulações aperfeiçoadas de levosimendana para administração intravenosa por infusão ou injeção e de concentrados para infusão
EP3373853A4 (fr) 2015-11-12 2019-07-10 St. Teresa Medical, Inc. Procédé de scellement d'une durotomie
CN108261398A (zh) * 2016-12-30 2018-07-10 齐鲁制药有限公司 一种含有左西孟旦的供注射用药物制剂及其制备方法
WO2019089717A1 (fr) 2017-11-02 2019-05-09 St. Teresa Medical, Inc. Produits de scellement à base de fibrine
CN111474289A (zh) * 2019-10-31 2020-07-31 武汉嘉诺康医药技术有限公司 一种利用反相色谱分离分析左西孟旦中右西孟旦的方法
CA3161960A1 (fr) 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. Levosimendan pour traiter l'hypertension pulmonaire accompagnee d'une insuffisance cardiaque au moyen d'une fraction d'ejection preservee (ph-hfpef)
CN111514147B (zh) * 2020-05-12 2021-09-17 成都欣捷高新技术开发股份有限公司 用于急性失代偿心力衰竭症状的左西孟旦钠药用组合物及制备方法
US11760730B2 (en) 2021-01-11 2023-09-19 Navinta, Llc Process for the preparation of high purity Levosimendan
WO2023027670A2 (fr) * 2021-08-23 2023-03-02 Tum Ekip Ilac Anonim Sirketi Compositions de lévosimendan lyophilisées
CN115518037A (zh) * 2022-10-14 2022-12-27 上药东英（江苏）药业有限公司 一种安全质量稳定的左西孟旦注射剂组合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2251615B (en) 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9606474D0 (en) 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI980902A (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaanin stabiileja koostumuksia
FI109659B (fi) * 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia

Also Published As

Publication number Publication date
NZ517605A (en) 2003-08-29
TWI242434B (en) 2005-11-01
HUP0202749A3 (en) 2003-03-28
NO20021090L (no) 2002-03-05
BR0013924B1 (pt) 2013-09-24
PL354028A1 (en) 2003-12-15
DE60025627T2 (de) 2006-11-16
CO5180582A1 (es) 2002-07-30
WO2001019334A3 (fr) 2001-11-15
HUP0202749A2 (hu) 2003-02-28
NO20021090D0 (no) 2002-03-05
EA200200348A1 (ru) 2002-08-29
HU228340B1 (en) 2013-03-28
CN1203855C (zh) 2005-06-01
RS50445B (sr) 2010-03-02
CN1373665A (zh) 2002-10-09
NO331989B1 (no) 2012-05-21
SI1210085T1 (sl) 2006-04-30
CZ303095B6 (cs) 2012-03-28
CA2382013C (fr) 2009-08-11
IS6296A (is) 2002-03-06
DE60025627D1 (de) 2006-04-06
CA2382013A1 (fr) 2001-03-22
KR100869752B1 (ko) 2008-11-21
PT1210085E (pt) 2006-05-31
BRPI0013924B8 (pt) 2021-05-25
EE05375B1 (et) 2011-02-15
UA73954C2 (uk) 2005-10-17
YU16902A (sh) 2004-09-03
IS2244B (is) 2007-05-15
IL148379A0 (en) 2002-09-12
BR0013924A (pt) 2002-05-21
IL148379A (en) 2006-12-10
JP2003509351A (ja) 2003-03-11
SK3272002A3 (en) 2002-12-03
AR025449A1 (es) 2002-11-27
MY125984A (en) 2006-09-29
HK1049282A1 (en) 2003-05-09
ATE315937T1 (de) 2006-02-15
AU7004400A (en) 2001-04-17
FI109659B (fi) 2002-09-30
HRP20020298A2 (en) 2003-06-30
JP4708648B2 (ja) 2011-06-22
CZ2002788A3 (cs) 2002-11-13
US6943164B2 (en) 2005-09-13
HRP20020298B1 (en) 2007-02-28
DK1210085T3 (da) 2006-05-08
AU771027B2 (en) 2004-03-11
US20040106617A1 (en) 2004-06-03
WO2001019334A2 (fr) 2001-03-22
ME00523B (me) 2011-10-10
FI19991925A (fi) 2001-03-10
TR200200620T2 (tr) 2002-09-23
EP1210085B1 (fr) 2006-01-18
BG65827B1 (bg) 2010-02-26
BG106589A (bg) 2002-11-29
US6730673B1 (en) 2004-05-04
EA005067B1 (ru) 2004-10-28
EE200200129A (et) 2003-04-15
KR20020048400A (ko) 2002-06-22
ES2256034T3 (es) 2006-07-16
EP1210085A2 (fr) 2002-06-05
HK1049282B (zh) 2005-12-30
PL202356B1 (pl) 2009-06-30
MXPA02002423A (es) 2002-08-12
ZA200201828B (en) 2003-08-27

Similar Documents

Publication Publication Date Title
SK287154B6 (sk) Vodný intravenózny infúzny roztok alebo farmaceutický roztok obsahujúci levosimendan
US20060154891A1 (en) Ready-to-use gemcitabine solutions and gemcitabin concentrates
SK285650B6 (sk) Vodné prípravky moxifloxacínu a chloridu sodného,spôsob ich výroby a kombinovaný preparát
KR102656841B1 (ko) 레파뮬린의 주사가능한 약제학적 제형
BG107748A (bg) Фармацевтичен състав на дронедарон за парентерално приложение
AU2004314154B2 (en) Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
US20030165568A1 (en) Stabilized steroidal suspension
US20080095786A9 (en) Compositions And Methods For Preventing And Treating Endotoxin-Related Diseases And Conditions
EP2303228B1 (fr) Composition de fosphénytoïne
US6187746B1 (en) Pharmaceutical compositions based on dalfopristine and on quinupristine, and preparation thereof
CN1611219A (zh) 左西孟旦药物组合物及其制备方法
US20110015221A1 (en) Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
EA023081B1 (ru) Инъекционная лекарственная форма флупиртина

Legal Events

Date Code Title Description
MK4A Expiry of patent

Expiry date: 20200908